洞察市场格局
解锁药品研发情报

400客服电话

  • 购买数据产品

    400-9696-311 转1

  • 定制咨询业务

    400-9696-311 转2

  • 数据与AI定制业务

    400-9696-311 转3

  • 商务合作及其他问题

    400-9696-311 转4

  • 投诉及建议

    400-9696-311 转5

医药数据查询

【ChiCTR2600127910】Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)

基本信息
登记号

ChiCTR2600127910

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-07-09

临床申请受理号

/

靶点

/

适应症

Dementia

试验通俗题目

Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)

试验专业题目

Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

000000

联系人通讯地址
请登录查看
临床试验信息
试验目的

1.To examine the effectiveness of an online psychosocial intervention in improving caregiving burden and care partners’ welling. 2.To study the care partners’ caregiving challenges and perception towards the intervention.

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Informed consent will be sought from each participant who fulfilled the inclusion and exclusion criteria. After baseline assessment, each participant will be randomised into intervention group and control group. The randomisation ratio will be 1:1 for the best interest of the participants and to ensure the internal validity . Random numbers with a 1:1 intervention : control ratio will be generated using Excel by a researcher not involved in the subject recruitment and baseline assessment in order to avoid researcher bias. The random numbers will be generated before the start of participant recruitment, and then be given to the researchers who screen and recruit participants.

盲法

If the data is collected via researcher interview, the data collector will be blinded to group allocation to avoid bias.

试验项目经费来源

N/A

试验范围

/

目标入组人数

145

实际入组人数

/

第一例入组时间

2026-08-01

试验终止时间

2031-07-31

是否属于一致性

/

入选标准

1. Hong Kong citizens aged 18 or above; 2. Currently providing at least eight hours per week of daily care to a relative or friend with dementia (defined by AD8 >= 2) [8]; 3. Able to communicate in Cantonese; 4. Able to use online meeting platforms such as Zoom or Microsoft Teams; 5. No plan to admit the care recipients to long-term care facility in the coming six months; 6. Not participated in BPSD counselling in the past three months; 7. Not receiving BPSD-related case management; 8. Care recipient is living in community; 9. Care recipient is not using dementia-specific day care or residential care service; 10. Care recipient has no known terminal illness; 11. Care recipient is in mild to moderate stage of dementia, defined by stage 4-6 of Functional Assessment Staging [9]; 12. You are able to participate in the assessment in this research; 13. Consent to research participation. 1. Hong Kong citizens aged 18 or above; 2. Currently providing at least eight hours per week of daily care to a relative or friend with dementia (defined by AD8 >= 2) [8];3. Able to communicate in Cantonese; 4. Able to use online meeting platforms such as Zoom or Microsoft Teams;5. No plan to admit the care recipients to long-term care facility in the coming six months;6. Not participated in BPSD counselling in the past three months;7. Not receiving BPSD-related case management;8. Care recipient is living in community;9. Care recipient is not using dementia-specific day care or residential care service;10. Care recipient has no known terminal illness;11. Care recipient is in mild to moderate stage of dementia, defined by stage 4-6 of Functional Assessment Staging [9];12. You are able to participate in the assessment in this research;13. Consent to research participation.;

排除标准

1. Non Hong Kong citizen; 2. Major psychiatric issue at the time of recruitment that may need more intensive intervention than psychoeducation; 3. You are not able to participate in the assessment in this research; 4. Not giving consent to research participation.;

研究者信息
研究负责人姓名
请登录查看
试验机构

Jockey Club Centre for Positive Ageing, the Chinese University of Hong Kong

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

000000

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Jockey Club Centre for Positive Ageing, the Chinese University of Hong Kong的其他临床试验

The Chinese University of Hong Kong的其他临床试验

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用

市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测

3,065亿元
2026年Q1总销售额
6.14%(2026Q1)
TOP5企业市场份额
药品销售排行榜
查看完整数据
2025Q4医院化学药销售增速 *按市场份额排序
  • 1
    甲氨蝶呤注射液
  • 2
    克霉唑阴道乳膏
  • 3
    氯化钠注射液
核心能力
  • 医药市场销售数据分析 · 医院、实体药店、网上药店
  • 市场竞争格局分析(靶点、药品类型、ATC大类)
更多信息,请进入市场洞察中心查看